E00-E90
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: consent to participating in the study; subject of consultation is either prescription of new medication or adjustment of preexisting pharmaco-therapy; Patients suffer from lipometabolic disorder and / or diabetes mellitus; minimum age 18 years; duration of therapy will be several weeks at least
Exclusion criteria
Exclusion criteria: limitation of linguistic, physical or cognitive functioning that could possibly preclude appropriate informing about the study or affect the prescribed medication therapy negatively; Patient initially refuses new prescription or adjustment of preexisting medication; new prescription or adjustment of preexisting medication are not subject of the actual conversation between patient and physician; the reason for the consultation is a therapy of an acute condition that will last less than two weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the guide's feasibility: is the guide feasible for clinical practice? Physicians will be surveyed by questionnaire after using the guide. | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfaction (physicians): questionnaire before and after using the guide, Satisfaction (patients): questionnaires (SIMS-D, KPF-A) applied to interventional and control-patients | — |
Countries
Germany
Contacts
Institut für Pharmakologie der Universität zu Köln